-+ 0.00%
-+ 0.00%
-+ 0.00%

SELLAS LIFE SCIENCES GROUP INC: FULL TOPLINE PHASE 2 DATA IN ACUTE MYELOID LEUKEMIA AND FDA REGULATORY REVIEW EXPECTED IN 1H 2025 FOR SLS009

Reuters·01/08/2025 13:20:50

Please log in to view news